MedPath

Fentanyl System

These highlights do not include all the information needed to use fentanyl transdermal system safely and effectively. See full prescribing information for fentanyl transdermal system. FENTANYL transdermal system for transdermal administration, CIIInitial U.S. Approval: 1968

Approved
Approval ID

ff9536e1-a4e8-4eb3-901c-ba9b86256672

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 16, 2022

Manufacturers
FDA

Lake Erie Medical DBA Quality Care Products LLC

DUNS: 831276758

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fentanyl

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55700-597
Application NumberANDA202097
Product Classification
M
Marketing Category
C73584
G
Generic Name
Fentanyl
Product Specifications
Route of AdministrationTRANSDERMAL
Effective DateAugust 15, 2022
FDA Product Classification

INGREDIENTS (2)

FentanylActive
Quantity: 25 ug in 1 1
Code: UF599785JZ
Classification: ACTIB
Methyl LaurateInactive
Code: 8IPS6BI6KW
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fentanyl System - FDA Drug Approval Details